QURE uniQure N.V.
Healthcare$25.15+3.97%ClosedMarket Cap: $1.57B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$35.44
Target (Median)
$35.00
Target Range
$10.00 - $60.00
Upside from current price: 40.9%
Rating Distribution
1 Strong Buy8 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-30 | Chardan Capital | maintain | Buy | Buy |
| 2026-04-20 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-03-23 | Barclays | maintain | Equal Weight | Equal Weight |
| 2026-03-11 | Mizuho | upgrade | Outperform | Neutral |
| 2026-03-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-09 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-09 | Wells Fargo | upgrade | Overweight | Equal Weight |
| 2026-03-09 | RBC Capital | upgrade | Outperform | Sector Perform |
| 2026-03-03 | Mizuho | downgrade | Neutral | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.05 | $92.5M | 8 |
| Sun Dec 31 | $-2.57 | $174.9M | 6 |
| Mon Dec 31 | $-1.01 | $324.7M | 4 |
| Tue Dec 31 | $0.61 | $482.3M | 2 |